TRU-SENTIMENT · DeltaNeutral
JANX Trading Analysis - 10/01/2026 11:13 AM — TRU-SENTIMENT
Options chain · Stock chart · Baseline chart
JANX (Janux Therapeutics Inc. Common Stock) at $16.80. True Sentiment Bearish, delta 40-60 call 0% / put 100%, call $0 vs put $387,750. RSI 46.0.
- Symbol
- JANX
- Price
- $16.80
- Article bias (separate from True Sentiment)
- neutral
- Conviction
- medium
- Published
- 2026-10-01 11:13:00 ET
- Author
- DeltaNeutral staff
TRUE SENTIMENT ANALYSIS (DELTA 40-60 OPTIONS)
True Sentiment Analysis — Delta 40–60 Options:Key Statistics: JANX
Fundamental Snapshot
Valuation
| EPS (trailing 12 mo) | $-1.64 |
| Market cap | $1.03B |
| Shares outstanding | 61.1M |
Dividend
| Dividend yield | 0.00% |
Risk & range
| Beta | 3.70 |
| 52-week low | $12.12 |
| 52-week high | $35.34 |
| Historical volatility | 53.2% |
Ownership & trading
| Institutional ownership | 41.8% |
| Average daily volume | 1.0M sh |
Reported figures; no analyst estimates.
📈 Analysis
JANX Trading Analysis
News Headlines & Context:
The embedded dataset does not include dated news headlines, company announcements, or an earnings calendar. Accordingly, no specific external headline can be independently verified within this analysis. The following are relevant event categories to monitor for JANX rather than reported headlines:
- ETF and market volatility: JANX trades with a reported beta of 3.70 and historical volatility of 53.24%, making broad risk-on/risk-off moves and volatility expansion important potential catalysts.
- Underlying portfolio developments: For an exchange-traded fund, constituent earnings, economic data, interest-rate expectations, and sector-specific news can create indirect price catalysts.
- Fund-flow and liquidity conditions: Changes in trading volume, spreads, and investor risk appetite can be significant for a high-volatility product such as JANX.
- Options positioning and expiration activity: The November 20, 2026 option expiration may attract hedging and speculative activity as expiration approaches.
- Recent price action: The supplied daily data shows a sharp decline from a 30-day high of $20.31 toward the $15.75–$16.00 area, followed by a partial recovery to $17.21 on September 30. This is the principal market context visible in the data.
Fundamental Analysis:
The available fundamental data is incomplete, so a conventional valuation assessment is not possible.
| Metric | JANX Data | Interpretation |
|---|---|---|
| Market capitalization | $1,026.80 million | Indicates a relatively small capitalization compared with large diversified ETFs. |
| Trailing EPS | -$1.64 | Negative trailing earnings make a traditional P/E valuation unavailable. |
| Trailing P/E | Not available | No meaningful trailing earnings multiple can be calculated. |
| Forward P/E | Not available | Forward earnings and valuation data were not supplied. |
| PEG ratio | Not available | No PEG-based growth-adjusted valuation comparison can be made. |
| Revenue growth | Not available | No revenue history or YoY growth rate was supplied. |
| Profit margins | Not available | Gross, operating, and net margin figures were not supplied. |
| Debt/equity | Not available | No balance-sheet leverage assessment is possible. |
| ROE | Not available | Return on equity cannot be evaluated. |
| Free cash flow | Not available | Cash-generation strength cannot be evaluated. |
| Dividend yield | 0.00% | No dividend income component is indicated by the supplied data. |
| Institutional ownership | 41.81% | Meaningful institutional participation may affect liquidity and trading behavior. |
| Beta | 3.70 | JANX is reported to have high sensitivity to broader market movements. |
| Historical volatility | 53.24% | Price fluctuations are expected to be substantial. |
Valuation: Because EPS is negative and neither forward P/E nor PEG is provided, JANX cannot be compared meaningfully with sector or peer multiples from this dataset. The $1,026.80 million market capitalization and high beta are more informative than unavailable valuation ratios.
Fundamental strengths: Institutional ownership is 41.81%, and the fund has substantial assets under market capitalization. The absence of a dividend is not a weakness for a product intended primarily for price appreciation.
Fundamental concerns: The supplied data lacks revenue growth, margins, debt/equity, free cash flow, ROE, analyst recommendations, and analyst price targets. The negative EPS also means earnings-based valuation support is unavailable. These gaps increase the importance of price, volatility, and portfolio-specific factors.
Current Market Position:
The daily closing price rose from $16.79 on September 29 to $17.21 on September 30, a gain of $0.42, or approximately 2.50%. However, the September 30 daily candle had an open of $17.08, a high of $17.56, a low of $16.79, and a close of $17.21. This indicates a recovery attempt, but not a decisive breakout above the September 30 high.
Relative to the 30-day range, the $17.21 price is approximately 32.04% of the way from the $15.75 low to the $20.31 high. The price therefore remains well below the upper end of the recent range, while also holding above the lower boundary.
The final five supplied minute bars show a short-term pullback from $16.92 to $16.78 before a small bounce to $16.79. This intraday sequence is weaker than the prior daily recovery and indicates short-term selling pressure into the final observed bar.
Technical Analysis:
Technical Indicators
Interactive charts load with JavaScript. This text is the crawlable summary.